Superior cycle control with a contraceptive vaginal ring compared with an oral contraceptive containing 30 g ethinylestradiol and 150 g levonorgestrel: a randomized trial

By Oddsson K.  

Human Reproduction, Vol. 20, Iss. 2, 2005-02 ,pp. : 557-562

Oxford University Press

Access to resources Recommend Favorite

User Experience with an Oral Contraceptive Containing Ethinylestradiol 30g and Drospirenone 3mg (Yasmin ® ) in Clinical Practice

By Schultz-Zehden Beate  

Treatments in Endocrinology, Vol. 5, Iss. 4, 2006-01 ,pp. : 251-256

Adis International

Access to resources Recommend Favorite

Effect of a combined oral contraceptive containing 20 μg ethinyl estradiol and 75 μg gestodene on hemostatic parameters

By Aldrighi José   Carneiro De Campos Luis   Eluf Gebara Otávio   Petta Carlos   Bahamondes Luis  

Gynecological Endocrinology, Vol. 22, Iss. 1, 2006-01 ,pp. : 1-4

Informa Healthcare

Access to resources Recommend Favorite

Increased plasma viscosity in young women with polycystic ovary syndrome using an oral contraceptive containing 35 μg ethinyl estradiol and 2 mg cyproterone acetate

By Markantes George   Saltamavros Alexandros D.   Vervita Vasiliki   Armeni Anastasia K.   Karela Anastasia   Adonakis George   Decavalas George   Georgopoulos Neoklis A.  

Gynecological Endocrinology, Vol. 27, Iss. 12, 2011-12 ,pp. : 971-977

Informa Healthcare

Access to resources Recommend Favorite

Fertility control. Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol

By Roumen F.J.M.E.  

Human Reproduction, Vol. 16, Iss. 3, 2001-03 ,pp. : 469-475

Oxford University Press

Access to resources Recommend Favorite